- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BMY
Recent news which mentions BMY
From Benzinga
Bear Market Bargains: 3 Dividend Stocks to Buy Now
October 03, 2022
From Motley Fool
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
From Benzinga
Bear Market: 2 Safe Stocks to Buy Right Now
September 28, 2022
From Motley Fool
From Benzinga
Bristol-Myers Squibb, Cash, Cheniere Energy And This Tech Company Are CNBC's Final Trades
September 23, 2022
From Benzinga
Salesforce Is Among Thursday's CNBC 'Fast Money' Final Trades
September 22, 2022
From Benzinga
Nanobiotix Establishes Recommended Dose For Registrational Study Of Head & Neck Combo Therapy Trial
September 22, 2022
From Benzinga
3 Stocks That Could Rocket on Biden’s Cancer Moonshot
September 20, 2022
From InvestorPlace
2 Biotech Stocks You Can Buy and Hold for the Next Decade
September 19, 2022
From Motley Fool
Amazon, Target And 3 Other Stocks Insiders Are Selling
September 19, 2022
From Benzinga
Bristol Myers' Opdivo Combo Treatment Scores European Approval For Skin Cancer Setting
September 19, 2022
Tickers
BMY
From Benzinga
7 Penny Stocks That Actually Have a Buy Rating
September 19, 2022
From InvestorPlace
US Stock Futures Down Ahead Of Fed's Rate Decision This Week, Crude Oil Drops Over 1%
September 19, 2022
From Benzinga
AutoZone, bluebird bio And 3 Stocks To Watch Heading Into Monday
September 19, 2022
From Benzinga
3 Stocks to Buy and Hold Forever
September 17, 2022
From Motley Fool
Why Ventyx Biosciences Zoomed Nearly 60% Higher This Week
September 16, 2022
From Motley Fool
Top US Drugmakers Exploit US Patent System To Keep Generic Competition At Bay: Report
September 16, 2022
From Benzinga
Bristol-Myers Squibb And 2 Other Stocks Insiders Are Selling
September 16, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2022
From Benzinga
Melanoma Study Achieves Key Milestone as Bristol's Flagship Treatment Secures Improvement in Survival Rates
September 15, 2022
Tickers
BMY
From Benzinga
These 5 Experts See A Market Crash Ahead: What Do BZ Readers Think?
September 14, 2022
From Benzinga
US Department Of Health, Defense To Inject $1B To Boost Domestic Biomanufacturing
September 14, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.